Leaflet PEGASYS 135mcg / 0.5ml solution for injection in pre-filled syringe
Indicated for: viral infections; multiple sclerosis; cancer
Route of administration: injectable
Substance: peginterferon alfa-2A (antineoplastic agent)
ATC: L03AB11 (Antineoplastic and immunomodulating agents | Immunostimulants | Interferons)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Peginterferon alfa-2a is an immunomodulatory agent used in the treatment of chronic hepatitis B and C. It works by stimulating the body's immune response to fight viral infections.
The medication is administered subcutaneously, as directed by a doctor, usually once a week. It is important for patients to follow the treatment regimen and undergo regular tests to monitor the response to therapy.
Patients should be aware of potential side effects, such as fatigue, fever, or flu-like symptoms. It is important to inform the doctor of any unusual symptoms.
Common side effects include fatigue, fever, and flu-like symptoms. In rare cases, severe reactions such as depression or hematologic disorders may occur. Patients should be informed of these risks before use.
General data about PEGASYS 135mcg / 0.5ml
- Substance: peginterferon alfa-2A
- Date of last drug list: 01-04-2014
- Commercial code: W52673003
- Concentration: 135mcg / 0.5ml
- Pharmaceutical form: solution for injection in pre-filled syringe
- Quantity: 1
- Product type: original
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Pharmaceutical forms available for peginterferon alfa-2A
Concentrations available for peginterferon alfa-2A
- 135mcg/0.5ml
- 135mcg/ml
- 180mcg/0.5ml
- 180mcg/ml